04 Nov 2011

1st Scientific & Industrial Committee – ACCELENCE Bordeaux Clinical Research Network

On September 9th 2011, ACCELENCE BORDEAUX CLINICAL RESEARCH NETWORK (BCRN) held the first Scientific & Industrial Committee at the Bordeaux Chamber of Commerce and Industry.

40 industry representatives (of wich 11 large pharmaceutical laboratoires and 4 international CROs), 30 key opinion leaders in numerous fields of expertise as well as dozen delegates from innovation support organizations attended this event, and event that also marked the launch and recognition of a first in public/private partnerships in Europe, an organizational innovation serving scientific and medical innovation.

On the same occasion, ACCELENCE BCRN, its founding members and QUINTILES signed a “PRIME SITE” partnership-agreement.

Download the 1st Scientific & Industrial Committee presentations:

Plenary Conference

Mme Lindy JONES, Head ISS Worldwide, QUINTILES: “THE PARTNERSHIPS AND CLINICAL RESEARCH ISSUES IN THE 21ST CENTURY”

Dr. Gérard SORBA, President – AFCROs (Chairman – CLINACT): “THE DEVELOPMENT OF THE CROs IN FRANCE, THE IMPACT OF A NEW PHARMACEUTICAL APPROACH ON THE RELATIONSHIP WITH INVESTIGATING PHYSICIANS”

Dr. Franck VIGNAL, Head of Clinical Operations at SANOFI: “THE ATTRACTIVENESS OF FRENCH CLINICAL RESEARCH”

Presentation of ACCELENCE

Pr. Michael FAYON, Department of Medical Pediatrics, Coordinator of the Clinical Investigation Center in Pediatrics: “CLINICAL INVESTIGATION CENTER IN PEDIATRICS, CHILDREN’S HOSPITAL – PELLEGRIN, BORDEAUX UNIVERSITY HOSPITAL”

Pr. Stéphane LAFITTE, Head of the Echocardiography Department at the Bordeaux University Hospital’s Cardiology Hospital Haut-Lévêque, Coordinator of the Cardiovascular Clinical Investigation Center: “CARDIOVASCULAR THEME CICp”

Themed workshops

Workshop 1: Neurology

Pr. Pierre PHILIP, Bordeaux University Hospital: “THE STRUCTURING OF CLINICAL RESEARCH IN CLINICAL TRIALS WITHIN THE NEUROSCIENCE COMMUNITY”

Pr. Jean-François DARTIGUES, Bordeaux University Hospital: “ALZHEIMER’S DISEASE AND ITS THERAPEUTIC ASPECTS”

Workshop 2: Oncology – Targeted therapies

Pr. Alain RAVAUD, Bordeaux University Hospital: “TARGETED ANTIANGIOGENIC THERAPIES IN CANCER OF THE KIDNEY”

Pr Hervé BONNEFOI, Bergonié Center for Oncology: “TARGETED THERAPIES AND BREAST CANCER: SOME EXAMPLES OF SYNERGY BETWEEN ACADEMY-AND-INDUSTRY-SPONSORED RESEARCH”

Workshop 3: Cardiology

Pr. Michel HAISSAGUERRE, Bordeaux University Hospital: “THE NEW THERAPEUTIC APPROACHES IN ELECTRICAL HEART MALFUNCTIONS”

Worskhop 4: Pharmacoepidemiology

Pr. Nicholas MOORE, Bordeaux University Hospital

Dr. Hubert MECHIN, REGISTRAT-MAPI

“THE NEW REGULATORY CONSTRAINTS IN POST-APPROVAL RESEARCH”

Workshop 5: Oncology – Interventional Radiology

Pr. Nicolas GRENIER, Bordeaux University Hospital: “THE DEVELOPMENT OF NEW DIAGNOSTIC STRATEGIES FOR NEW TARGETED THERAPIES”

Dr. Jean PALUSSIERE, Bergonié Center for Oncology: “IMAGE GUIDED TUMOR DESTRUCTION BY TEMPERATURE ”

Workshop 6: Metabolic Syndromes

Pr. Bogdan CATARGI, Bordeaux University Hospital

Dr. Edouard GERBAUD, Bordeaux University Hospital

“MULTIDISCIPLINARY CLINICAL RESEARCH IN ENDOCRINOLOGY AND DIABETOLOGY IMPROVES THE QUALITY OF CARE”

Mot clés : , , , , , , , , , , , , , , , , , , , , ,